ArticleJournal of anaesthesiology, clinical pharmacology

Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis.

Mona K Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.